The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

Share Price Information for Surface Transforms (SCE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.20
Bid: 1.15
Ask: 1.25
Change: 0.025 (2.13%)
Spread: 0.10 (8.696%)
Open: 1.175
High: 1.20
Low: 1.175
Prev. Close: 1.175
SCE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Video | Surface Transforms (SCE) Open Offer and Q&A

29 Nov 2023 11:06

Hardman & Co Research Hardman & Co Video | Surface Transforms (SCE) Open Offer and Q&A 29-Nov-2023 / 11:06 GMT/BST The issuer is solely responsible for the content of this announcement.


Hardman Talks Video | Surface Transforms

Surface Transforms Open Offer and Q&A

Following the recent announcement of a placing and public offer by Surface Transforms, the management team of David Bundred, chairman, Kevin Johnson, CEO, and Isabelle Maddock, CFO, appeared on Hardman Talks to explain the need for further funding. This will support the expansion in manufacturing capacity, itself driven by strong customer demand. Watch it here: https://youtu.be/FWWNhGPfrds

In this update to investors SCE provides detail on the roll-out of its recent production starts on five models and the steps taken on increasing output. SCE currently has financial resources – a debt line is in the last stages of approval – to fund expansion to £150m annual sales capacity by 2027 with the benefit of modelled cash generation to 2027, and then beyond.

The most pressing issue for investors is the delay in achieving the fourfold production rise for which the production line has been expanded. Output in October ran at £1m, which is a rise of two-and-a-half times compared with the average rate last year. De-bottlenecking is the key, as there are seven 'single points of failure ' in the ca. 30-step production process. SCE has already paid for and is installing production equipment to raise capacity further, to £50m p.a. sales. The de-bottlenecking of processes on the existing enlarged line has driven turnover expectations and estimates for 2024E and the progressive roll-out of the £50m capacity impacts in stages through the year, leaving SCE with scope for elimination of the bottlenecks in this next year.

With only one competitor in a large and rapidly growing auto component market with at least three major environmental advantages – weight, particulates and end-of-life – the delivery on the £390m order book is the constraint to sales. Demand most certainly is not. The order book is to 12 models, stretching ca. seven years, with five currently live. SCE updated on its strong relationship with its customers, which remains cooperative and good. The next update is anticipated in January 2024.

Watch the recording: https://youtu.be/FWWNhGPfrds

Read more about the event here: https://hardmanandco.com/hardman-talks-surface-transforms-open-offer-qa/

To be first in the know about Hardman & Co’s latest digital events, subscribe to the mailing list here.

The Hardman Talks series is designed to share the latest sector insights and company investment cases from our corporate clients and our expert team of analysts. Click here to subscribe to the Hardman Talks channel on YouTube.

Hardman & Co | 9 Bonhill Street | London | EC2A 4DJ | www.hardmanandco.com

 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors’ understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies’ profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1784621 29-Nov-2023 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
10th Nov 20217:00 amRNSDirector/PDMR Shareholding
20th Sep 20214:35 pmEQSHardman & Co Research : Hardman Talks Video | Surface Transforms Management Presentation
13th Sep 20217:00 amRNSHalf-year Financial Report
2nd Sep 20217:01 amRNSNew manufacturing strategy
2nd Sep 20217:00 amRNSContract Award from OEM 5
17th Aug 20217:00 amRNSContract award from OEM 10 and notice of results
8th Jul 20217:00 amRNSTrading and operations update
5th Jul 20213:00 pmRNSExercise of options
9th Jun 20218:45 amEQSHardman & Co Research : Hardman Talks Video| Surface Transforms Management Presentation
2nd Jun 20219:43 amRNSResult of Annual General Meeting
28th May 202111:18 amRNSExercise of Options
27th May 202111:51 amRNSMeet the Directors and Q&A
25th May 20217:00 amRNSDirector Dealing
20th May 20219:30 amEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms - Q&A with the Board
13th May 20217:00 amRNSDirector Dealing
4th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
22nd Apr 20215:38 pmRNSPDMR Dealing
22nd Apr 20215:33 pmRNSDirector Dealing
19th Apr 20215:46 pmRNSExercise of Options
13th Apr 20217:00 amRNSDirector Dealing
12th Apr 20217:00 amRNSPreliminary Results and Notice of AGM
24th Mar 20217:00 amRNS£1 million loan agreement with LCRCA
15th Mar 20213:55 pmEQSHardman & Co Research: Surface Transforms (SCE): Everything has come together
15th Mar 20217:00 amRNSRetirement of NED & update on preliminary results
5th Mar 20217:00 amRNSAppointment of non-executive directors
24th Feb 20217:00 amRNSGrant of Options
18th Feb 20213:15 pmRNSCorrection: Exercise of Options
18th Feb 20218:54 amRNSExercise of Options
15th Feb 20217:00 amRNSPDMR Dealing
12th Feb 202111:31 amRNSDirector Dealing
11th Feb 20212:39 pmRNSHolding(s) in Company
10th Feb 202112:37 pmRNSHolding(s) in Company
10th Feb 202111:14 amRNSExercise of Options
10th Feb 202111:10 amRNSHolding(s) in Company
8th Feb 202110:35 amRNSResult of General Meeting
8th Feb 20217:00 amRNSResult of Over-Subscribed Open Offer
2nd Feb 20212:30 pmEQSHardman & Co Research : Hardman Talks video release - Surface Transforms management discuss fundraising
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSOnline investor presentation
20th Jan 20218:09 amRNSResult of Placing and Subscription, & Notice of GM
19th Jan 20215:35 pmRNSProposed Placing, Subscription and Open Offer
8th Jan 20215:13 pmRNSReplacement announcement - director dealings
5th Jan 20217:00 amRNSTrading, OEM Pipeline & Operations Update
30th Nov 20209:48 amRNSDirector Dealing
19th Nov 20205:59 pmRNSExercise of Options
22nd Oct 20204:44 pmRNSDirector Dealing
21st Oct 20207:00 amRNSGrant of Options
6th Oct 20203:37 pmRNSPDMR dealing
6th Oct 20203:26 pmRNSDirector dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.